BCM
HOWL icon

Bridgeway Capital Management’s Werewolf Therapeutics HOWL Stock Holding History

Bridgeway Capital Management’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.1K Hold
77,000
– – ﹤0.01% 1171
2025
Q4 		$48.8K Sell
77,000
-25,000
-25% -$30.4K ﹤0.01% 1184
2025
Q3 		$201K Hold
102,000
– – ﹤0.01% 1008
2025
Q2 		$111K Buy
102,000
+62,414
+158% +$64.2K ﹤0.01% 1053
2025
Q1 		$38.5K Sell
39,586
-70,000
-64% -$91.7K ﹤0.01% 1133
2024
Q4 		$162K Buy
109,586
+21,500
+24% +$43.8K ﹤0.01% 1041
2024
Q3 		$187K Sell
88,086
-37,000
-30% -$84.2K ﹤0.01% 1082
2024
Q2 		$305K Buy
125,086
+40,000
+47% +$192K 0.01% 969
2024
Q1 		$551K Hold
85,086
– – 0.01% 898
2023
Q4 		$328K Sell
85,086
-10,425
-11% -$26.6K 0.01% 1051
2023
Q3 		$204K Buy
95,511
+10,000
+12% +$27.6K 0.01% 1097
2023
Q2 		$261K Buy
85,511
+3,800
+5% +$10.7K 0.01% 1073
2023
Q1 		$212K Hold
81,711
– – 0.01% 1094
2022
Q4 		$168K Buy
81,711
+40,000
+96% +$105K ﹤0.01% 1130
2022
Q3 		$188K Buy
41,711
+5,500
+15% +$29.9K 0.01% 1153
2022
Q2 		$148K Buy
+36,211
New +$165K ﹤0.01% 1153

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bridgeway Capital Management's HOWL Position: Q1 2026 in Review

Bridgeway Capital Management held its Werewolf Therapeutics (HOWL) position steady in Q1 2026 at 77,000 shares worth $64.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1171.

Bridgeway Capital Management first reported a position in HOWL in Q2 2022 and has held it in 16 quarters since. The position peaked at $551K in Q1 2024. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • Bridgeway Capital Management held 77,000 shares of Werewolf Therapeutics worth $64.1K as of Q1 2026.
  • Bridgeway Capital Management left its Werewolf Therapeutics share count unchanged in Q1 2026.
  • Werewolf Therapeutics made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #1171 holding.
  • Bridgeway Capital Management first reported a position in Werewolf Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • Bridgeway Capital Management's Werewolf Therapeutics position peaked at $551K in Q1 2024.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.